Agilon Health AGL Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -7.8%-3.0pp | -4.8%+0.6pp | -5.4%-1.0pp | -4.4%+20.1pp | |
| Net margin | -6.6%-2.3pp | -4.3%+1.8pp | -6.1%-1.6pp | -4.5%+22.3pp | |
| EBITDA margin | -7.3%-2.9pp | -4.4%+0.5pp | -4.9%-1.1pp | -3.8%+19.7pp | |
| Free cash flow margin | -2%— | —— | -4%+2.1pp | -6.1%+4.0pp | |
| Returns | |||||
| Return on equity | -131%-85.0pp | -45.9%-15.1pp | -30.8%-20.8pp | -10%— | |
| Return on assets | -26%-11.1pp | -15%+0.3pp | -15.3%-8.8pp | -6.5%+33.5pp | |
| Efficiency | |||||
| Asset turnover | 3.9×+0.5× | 3.5×+1.0× | 2.5×+1.1× | 1.5×0.0× | |
| Liquidity | |||||
| Current ratio | 1×-0.2× | 1.3×-0.2× | 1.5×-1.2× | 2.7×-1.1× | |
| Quick ratio | 1×-0.2× | 1.3×-0.2× | 1.5×-1.2× | 2.7×-1.1× | |
| Cash ratio | 0.2×0.0× | 0.2×+0.1× | 0.1×-0.8× | 0.9×-2.1× | |
| Leverage | |||||
| Debt-to-equity | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -69.8×-22.5× | -47.3×-12.4× | -34.9×-11.4× | -23.5×+37.1× | |
| Per Share | |||||
| Book value per share | $0.31-73.3% | $1.15-29.2% | $1.62-36.6% | $2.55-12.9% | |
| Valuation | |||||
| Market capitalization | $285.52M-63.5% | $782.83M-84.6% | $5.1B-23.3% | $6.65B-37.5% | |
| Enterprise value | $148.62M-76.5% | $632.94M-87.4% | $5.03B-19.2% | $6.23B-35.4% | |
| Price / sales | 0×-0.1× | 0.1×-1.1× | 1.2×-1.6× | 2.8×-4.2× | |
| Price / book | 2.3×+0.6× | 1.7×-6.0× | 7.7×+1.3× | 6.4×-3.3× | |
| EV / sales | 0×-0.1× | 0.1×-1.1× | 1.2×-1.4× | 2.6×-3.7× | |
| Free cash flow yield | -41.7%— | —— | -3.4%-1.2pp | -2.2%-0.7pp | |
| Earnings yield | -137.1%-104pp | -33.2%-28.1pp | -5.2%-3.6pp | -1.6%+2.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Agilon Health's ratios come from?
- Every ratio is computed from Agilon Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.